CME Stock Price Today (October 2026) — CME Group Inc. Analysis & Key Metrics 2026-10-07
CME Group Inc. (CME) is trading at $270.27, up 0.03% today (as of October 2026). The stock continues to show mixed signals with a short-term dip within a broader uptrend, attracting attention from investors looking for Financial Services growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $283.60 (4.9% upside).
- Volatility is low (18.82% annualized), implying relatively contained price movements for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: steady revenue (0.80% YoY) alongside competitive pressures in the Financial Data & Stock Exchanges space.
CME Stock Analysis: Key Metrics & Valuation (October 2026)
Concise, actionable data for investors
CME Group Inc. - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $98.78B
P/E Ratio
Forward P/E: 22.08
Revenue Growth
Year over Year
Analyst Target
+4.9% upside potential
Key Investor Questions About CME
What investors need to know before buying
Based on current market data, CME presents a neutral technical setup with mixed signals fundamentals.
- Technicals say: Neutral (RSI 52.91)
- Fundamentals say: Mixed signals (nuanced financial profile)
CME's growth trajectory depends on its ability to expand within the Financial Data & Stock Exchanges sector while managing margin pressures.
- Future growth will depend on performance in core Financial Data & Stock Exchanges operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for CME investors include debt exposure and competitive dynamics in the Financial Data & Stock Exchanges industry.
- $3.87B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Financial Data & Stock Exchanges.
52-Week Trading Range
Over the past year, CME stock traded between $218.31 and $329.16 and currently trades in the middle of that range. Big swings are less likely unless a major catalyst emerges.
Volatility & Risk Profile
With 18.82% annualized volatility and β=-0.34, the stock exhibits low sensitivity to market moves—making CME suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional ownership with low short interest suggests steadier hands and low immediate risk.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Is CME Group (CME) A Bargain Following Its New Leveraged Loan Futures Launch?
CME Group’s new leveraged loan futures open another revenue stream to watch CME Group (CME) has just started trading S&P UBS USD Liquid Leveraged Loan Index futures, giving investors the first exchange listed contract tied to a transparent leveraged loan benchmark. CME Group shares trade at US$268.91 after a recent soft patch, with the 30-day share price return down 3.03%. Momentum over the past quarter has been stronger, with a 90-day share price return of 21.68%. Set against that near-term...
Bitcoin Cash Rallies 30% Following CME Futures Announcement
CME Group just triggered a 30% spike in Bitcoin Cash, but the last three coins to get the same futures announcement lost over a third of their value before trading even began. A surprise Grayscale filing may be the only thing standing between BCH and the same fate.
CME Expands Crypto Futures Lineup With Bitcoin Cash and Uniswap
The exchange operator is adding standard and micro contracts for BCH and UNI, extending a pattern of altcoin rollouts that already covers Cardano, Chainlink, Stellar, Avalanche, and Sui.
CME Group to Launch Bitcoin Cash and Uniswap Futures
CME Group (NASDAQ: $CME) plans to launch futures contracts for Bitcoin Cash (CRYPTO: $BCH) and Uniswap (CRYPTO: $UNI) on Octo...
CME Group Expands Equity Derivatives With New Factor Futures
CME expands equity derivatives with new factor futures, offering targeted exposure, margin offsets and flexible trading for institutions.
2 Altcoins Just Got Wall Street's Stamp of Approval: What Happens Next?
CME Group just opened 2 altcoins to Wall Street. Both spiked in minutes — but history has a warning for anyone buying this news.
Not Just Banks: 3 Trading Stocks to Watch After the Fed Rate Hike
The Fed raised rates 25 basis points on Sept. 16, and brokers and exchanges like Interactive Brokers, Robinhood, and CME Group stand to benefit from the new hiking cycle.
CME Group (CME) Debuts New Loan Futures As Metals Trading Hits Records
CME Group (NasdaqGS:CME) introduced S&P UBS USD Liquid Leveraged Loan Index futures, adding a new tool for leveraged loan exposure. The contract is based on the S&P UBS USD Liquid Leveraged Loan Index, jointly developed with S&P Dow Jones Indices and UBS. Management highlighted record 24/7 trading activity in gold and silver futures, noting strong retail engagement in precious metals. The group outlined significant executive promotions and leadership transitions as part of its planned...
CME Group Rises 5.8% in a Year: How Should You Play the Stock?
CME is expanding through higher trading volumes, new derivatives products and record market-data revenues while returning capital to shareholders.
CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?
CME's 62% net margin towers over Morningstar's 15.3%, but valuation metrics tell a different story for 2026 investors.
Explore More Analysis for CME
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
Next report Oct 21, 2026 (before the open)
Frequently Asked Questions
Common investor questions about CME Group Inc.
CME Group Inc. (CME) is currently trading at $270.27. The RSI (14-day) is at 52.9, indicating neutral territory. Wall Street analysts have a consensus "hold" recommendation. The mean analyst price target of $283.60 implies 4.9% upside from current levels. Volatility is low at 18.8% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for CME Group Inc. (CME): The trailing P/E ratio is 23.77, which is in line with broader market averages. The forward P/E is 22.08, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 4.93, above 2.0, suggesting the stock may be overvalued relative to its expected growth. Price-to-Book is 3.80. Price-to-Sales is 14.92. Valuation should be compared to Financial Data & Stock Exchanges industry peers for context, as different sectors trade at different multiples.
Based on 15 analysts covering CME, the consensus price target is $283.60. This represents a 4.9% upside from the current price of $270.27. The range spans from a low target of $230.00 to a high target of $330.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "hold". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, CME Group Inc. (CME) pays a dividend with a current yield of approximately 1.92%. The annualized dividend rate is $5.10 per share. The payout ratio is 95.4%, which is relatively high—earnings cover the dividend but there's limited room for increases. The most recent ex-dividend date was Sep 9, 2026.
Key risks for CME Group Inc. (CME) investors include: 1. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 2. Financial Data & Stock Exchanges sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is CME Group Inc.'s (CME) current debt and financial health profile: Total debt stands at $3.87B. The debt-to-equity ratio is 0.15x, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 1.02, indicating adequate short-term liquidity. The quick ratio is 0.02. The company holds $2.28B in cash and equivalents. Free cash flow is positive at $2.91B, providing a cushion for debt servicing and shareholder returns.